...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM webcast 9/12/2018

I echo Bears thanks to those attending the AGMs. The note have been invaluable.

GLTA

Toinv

Share
New Message
Please login to post a reply